Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1123 of 1,261
  1. US 6958151

    Miniprotein ligands and other polypeptides and methods for making and using same

    The Board of Regents of the University of Texas System Β· Granted Oct 25, 2005 Β· Expires Oct 20, 2025

    expired
  2. US 6958238

    Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof

    The Regents of the University of California Β· Granted Oct 25, 2005 Β· Expires Oct 20, 2025

    expired
  3. US 6958321

    Isolation, characterization, cloning and use of a mushroom lectin

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Oct 25, 2005 Β· Expires Oct 20, 2025

    expired
  4. US 6958342

    Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-Ξ±]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

    Neurocrine Biosciences, Inc. Β· Granted Oct 25, 2005 Β· Expires Oct 20, 2025

    expired
  5. US 2005233966

    Methods for controlling angiogenesis and cell proliferation

    CANYON PHARMACEUTICALS INC [US] Β· Granted Oct 20, 2005 Β· Expires Oct 15, 2025

    expired
  6. US 6956060

    Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Oct 18, 2005 Β· Expires Oct 13, 2025

    expired
  7. US 6955895

    Thymic stromal lymphopoietin receptor molecules and uses thereof

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA Β· Granted Oct 18, 2005 Β· Expires Oct 13, 2025

    expired
  8. US 6955894

    Method for producing TNF receptor releasing enzyme

    The Regents of the University of California Β· Granted Oct 18, 2005 Β· Expires Oct 13, 2025

    expired
  9. US 6956053

    Pyrazole derivatives and their use as gastrin and cholecystokin receptor ligands

    The James Black Foundation Limited Β· Granted Oct 18, 2005 Β· Expires Oct 13, 2025

    expired
  10. US 6956145

    Mice models of human prostate cancer progression

    The Regents of the University of California Β· Granted Oct 18, 2005 Β· Expires Oct 13, 2025

    expired
  11. US 6953840

    Methods of using non-human animal Apolipoprotein A-I protein

    Esperion Therapeutics, Inc. Β· Granted Oct 11, 2005 Β· Expires Oct 6, 2025

    expired
  12. US 6953779

    Melanocortin receptor antagonists and modulations of melanocortin receptor activity

    The Regents of the University of California Β· Granted Oct 11, 2005 Β· Expires Oct 6, 2025

    expired
  13. US 6953789

    Thiol compounds, their production and use

    Takeda Chemical Industries Ltd. Β· Granted Oct 11, 2005 Β· Expires Oct 6, 2025

    expired
  14. US 6953834

    Transcription factors related to TFIIA

    The Board of Regents of the University of Texas System Β· Granted Oct 11, 2005 Β· Expires Oct 6, 2025

    expired
  15. US 6953786

    Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof

    The Regents of the University of California Β· Granted Oct 11, 2005 Β· Expires Oct 6, 2025

    expired
  16. US 6953575

    Methods of treating central nervous system disorders using viral vectors

    The Regents of the University of California Β· Granted Oct 11, 2005 Β· Expires Oct 6, 2025

    expired
  17. WO 2005092872

    INHIBITEURS DE PEPTIDE DEFORMYLASE

    ARPIDA AS [DK] Β· Granted Oct 6, 2005 Β· Expires Oct 1, 2025

    expired
  18. US 6951885

    Pharmaceutical composition

    Takeda Pharmaceutical Company Limited Β· Granted Oct 4, 2005 Β· Expires Sep 29, 2025

    expired
  19. US 6951653

    Streptococcal C5a peptidase vaccine

    Regents of the University of Minnesota Β· Granted Oct 4, 2005 Β· Expires Sep 29, 2025

    expired
  20. US 6951942

    Glucocorticoid-selective anti-inflammatory agents

    Ligand Pharmaceuticals Incorporated Β· Granted Oct 4, 2005 Β· Expires Sep 29, 2025

    expired
  21. US 6951917

    MHC-class II restricted melanoma antigens and their use in therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 4, 2005 Β· Expires Sep 29, 2025

    expired
  22. US 6951847

    Methods of treating fungal infections using lupeol

    Regents of the University of Minnesota Β· Granted Oct 4, 2005 Β· Expires Sep 29, 2025

    expired
  23. US 6951846

    Artemisinins with improved stability and bioavailability for therapeutic drug development and application

    The United States of America as represented by the Secretary of the Army Β· Granted Oct 4, 2005 Β· Expires Sep 29, 2025

    expired
  24. US 6951743

    Hyaluronan synthase genes and expression thereof in bacillus hosts

    University of Oklahoma Board of Regents Β· Granted Oct 4, 2005 Β· Expires Sep 29, 2025

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.